XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Interim Condensed Consolidated Statements of Cash Flows
€ in Thousands, $ in Millions
9 Months Ended
Sep. 30, 2022
EUR (€)
Sep. 30, 2021
EUR (€)
Operating activities    
Loss before income tax € (120,405) € (407,939)
Adjustments to reconcile loss before tax to net cash flows    
Finance income (10,619) (8,828)
Finance expense 3,077 10,015
Depreciation and impairment of property, plant and equipment and right-of-use assets 23,349 11,342
Loss on disposal of fixed assets 6,428  
Impairment of inventory and prepayments 41,295 39,142
Share-based payment expense 6,455 11,470
Non-cash income from release of provisions (61,102)  
Working capital changes    
Decrease / (increase) in trade receivables and contract assets 12,334 (7,810)
Decrease / (increase) in inventory 6,996 (143,638)
Decrease / (increase) in other assets (9,724) (214,621)
Receipts from grants from government agencies and similar bodies   38,349
(Decrease) / increase in trade and other payables, other liabilities and contract liabilities (131,746) 130,022
(Decrease) / increase in other current financial liabilities   78
Decrease / (increase) in deferred taxes 49 (100)
Income taxes paid (152) (352)
Interest received   25
Interest paid (3,326) (7,212)
Net cash flow (used in) operating activities (237,091) (550,057)
Investing activities    
Purchase of property, plant and equipment (67,124) (91,032)
Purchase of intangible assets (5,435) (2,273)
Net cash flow (used in) investing activities (72,559) (93,305)
Financing activities    
Payments on lease obligations (3,087) (2,346)
Payment on / Proceeds from Treasury Shares 991 (23,339)
Proceeds from at-the-market offering program (net of transaction costs) 32,325  
Payments from the exercise of options (356)  
Proceeds from the issuance of shares (net of transaction costs)   404,164
Net cash flow provided by financing activities 29,873 378,479
Net increase (decrease) in cash and cash equivalents (279,777) (264,883)
Currency translation gains (losses) on cash and cash equivalents 9,178 3,261
Cash and cash equivalents, beginning of period 811,464 1,322,593
Cash and cash equivalents, end of period € 540,865 € 1,060,971